Accuray (ARAY) Competitors $1.94 +0.07 (+3.74%) (As of 01:00 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends ARAY vs. OFIX, SRDX, ANGO, RMTI, RSLS, ABT, ISRG, SYK, BSX, and MDTShould you be buying Accuray stock or one of its competitors? The main competitors of Accuray include Orthofix Medical (OFIX), Surmodics (SRDX), AngioDynamics (ANGO), Rockwell Medical (RMTI), ReShape Lifesciences (RSLS), Abbott Laboratories (ABT), Intuitive Surgical (ISRG), Stryker (SYK), Boston Scientific (BSX), and Medtronic (MDT). These companies are all part of the "health care equipment" industry. Accuray vs. Orthofix Medical Surmodics AngioDynamics Rockwell Medical ReShape Lifesciences Abbott Laboratories Intuitive Surgical Stryker Boston Scientific Medtronic Accuray (NASDAQ:ARAY) and Orthofix Medical (NASDAQ:OFIX) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, community ranking, valuation, media sentiment, earnings, analyst recommendations, risk, institutional ownership and dividends. Is ARAY or OFIX more profitable? Accuray has a net margin of -3.72% compared to Orthofix Medical's net margin of -15.18%. Orthofix Medical's return on equity of -21.25% beat Accuray's return on equity.Company Net Margins Return on Equity Return on Assets Accuray-3.72% -36.93% -3.52% Orthofix Medical -15.18%-21.25%-13.29% Which has higher valuation & earnings, ARAY or OFIX? Accuray has higher earnings, but lower revenue than Orthofix Medical. Accuray is trading at a lower price-to-earnings ratio than Orthofix Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAccuray$444.20M0.42-$15.55M-$0.17-10.96Orthofix Medical$784.25M0.85-$151.40M-$3.13-5.55 Do institutionals and insiders believe in ARAY or OFIX? 64.1% of Accuray shares are owned by institutional investors. Comparatively, 89.8% of Orthofix Medical shares are owned by institutional investors. 4.2% of Accuray shares are owned by insiders. Comparatively, 2.6% of Orthofix Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Does the MarketBeat Community favor ARAY or OFIX? Orthofix Medical received 81 more outperform votes than Accuray when rated by MarketBeat users. However, 65.61% of users gave Accuray an outperform vote while only 61.92% of users gave Orthofix Medical an outperform vote. CompanyUnderperformOutperformAccurayOutperform Votes33265.61% Underperform Votes17434.39% Orthofix MedicalOutperform Votes41361.92% Underperform Votes25438.08% Which has more volatility and risk, ARAY or OFIX? Accuray has a beta of 1.44, indicating that its share price is 44% more volatile than the S&P 500. Comparatively, Orthofix Medical has a beta of 1.09, indicating that its share price is 9% more volatile than the S&P 500. Do analysts rate ARAY or OFIX? Accuray currently has a consensus target price of $9.00, indicating a potential upside of 382.83%. Orthofix Medical has a consensus target price of $23.00, indicating a potential upside of 32.34%. Given Accuray's stronger consensus rating and higher possible upside, analysts plainly believe Accuray is more favorable than Orthofix Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Accuray 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Orthofix Medical 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.75 Does the media favor ARAY or OFIX? In the previous week, Accuray had 2 more articles in the media than Orthofix Medical. MarketBeat recorded 3 mentions for Accuray and 1 mentions for Orthofix Medical. Accuray's average media sentiment score of 0.41 beat Orthofix Medical's score of 0.38 indicating that Accuray is being referred to more favorably in the media. Company Overall Sentiment Accuray Neutral Orthofix Medical Neutral SummaryAccuray beats Orthofix Medical on 11 of the 18 factors compared between the two stocks. Ad Prosper Trading AcademyA.I. Trading System Helps Some Traders Pocket $1,100 per DAY!What if I told you 60 seconds a day could completely change your life? This AI-powered trading system finds high-probability option trades in less than 60 seconds a dayClick HERE to access this powerful AI Trading System Get Accuray News Delivered to You Automatically Sign up to receive the latest news and ratings for ARAY and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ARAY vs. The Competition Export to ExcelMetricAccuraySurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$187.45M$4.34B$5.18B$9.21BDividend YieldN/A44.59%5.12%4.30%P/E Ratio-10.9624.8987.6517.17Price / Sales0.4252.631,165.15121.16Price / CashN/A43.4043.2337.84Price / Book4.147.084.794.79Net Income-$15.55M$13.64M$120.46M$225.43M7 Day Performance-2.41%0.65%-0.97%-0.12%1 Month Performance-3.42%-0.50%15.25%1.56%1 Year Performance-35.05%39.04%29.71%16.07% Accuray Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ARAYAccuray4.5915 of 5 stars$1.94+3.7%$9.00+363.9%-34.8%$195.10M$444.20M-11.41987OFIXOrthofix Medical2.762 of 5 stars$17.44+0.1%$23.00+31.9%+22.0%$666.45M$784.25M-5.571,634Positive NewsSRDXSurmodics4.4098 of 5 stars$39.59-0.4%$50.00+26.3%+7.0%$567.17M$126.08M-48.88376Positive NewsANGOAngioDynamics4.0623 of 5 stars$8.64-2.8%$12.00+38.9%+11.3%$351.08M$292.73M-1.42748Gap DownRMTIRockwell Medical4.1373 of 5 stars$2.12+1.9%$6.00+183.0%+11.6%$68.52M$98.92M-42.40300Analyst ForecastRSLSReShape Lifesciences0.8139 of 5 stars$4.28-2.3%N/A-75.3%$3.05M$8.18M0.0050Positive NewsGap UpABTAbbott Laboratories4.8893 of 5 stars$113.70-0.5%$130.71+15.0%+4.8%$197.21B$41.22B34.56114,000ISRGIntuitive Surgical4.6136 of 5 stars$522.62-0.3%$554.17+6.0%+56.8%$186.15B$7.87B84.0213,676SYKStryker4.952 of 5 stars$366.07+0.4%$405.80+10.9%+23.2%$139.55B$21.97B39.2452,000BSXBoston Scientific4.3381 of 5 stars$89.70+0.8%$95.96+7.0%+60.8%$132.20B$15.91B74.1348,000MDTMedtronic4.9454 of 5 stars$80.990.0%$95.00+17.3%-0.6%$103.85B$33.00B24.7795,000 Related Companies and Tools Related Companies OFIX Alternatives SRDX Alternatives ANGO Alternatives RMTI Alternatives RSLS Alternatives ABT Alternatives ISRG Alternatives SYK Alternatives BSX Alternatives MDT Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:ARAY) was last updated on 12/24/2024 by MarketBeat.com Staff From Our PartnersURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredA.I. Trading System Helps Some Traders Pocket $1,100 per DAY!What if I told you 60 seconds a day could completely change your life? This AI-powered trading syst...Prosper Trading Academy | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWall St. Icon: “If you wait on this, it will already be too late”If you have a significant amount of money in the stock market right now — or if you're sitting on the sideline...InvestorPlace | SponsoredElon Musk could help pay for your retirementElon Musk is the richest man in the world... And he's pouring trillions into a unique investment.Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Accuray Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Accuray With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.